Share
2,333 Posts.
lightbulb Created with Sketch. 26
clock Created with Sketch. 11/04/18
13:21
Share
Originally posted by Fact Finder
↑
"This is truly a proof of concept for this first-in-class drug candidate." said Arun Sanyal, Professor of Gastroenterology and Hepatology from the Virginia Commonwealth University in Richmond, USA and the study lead Principle Investigator. ".......We are encouraged that IMM-124E, a drug with an exceptional safety profile, can lower the LPS-associated inflammatory burden and improve liver enzymes. The potential clinical applications for this drug candidate are numerous and very exciting indeed"
Expand
Yep - I agree
